Compandia Appoints Dr Dave Tapolcazy as new Non Executive Chairman

News   May 14, 2010

 
Compandia Appoints Dr Dave Tapolcazy as new Non Executive Chairman
 
 
 

RELATED ARTICLES

Apple Allergens as an Effective Option for Treating Apple Allergy

News

Researchers have now proven in a Phase II trial that the apple allergen "Mal d 1" significantly reduces the symptoms of apple allergy and is therefore an effective and safe treatment option.

READ MORE

AIDS Vaccine Design: New Data Offers Important Insight

News

New data published in Immunity further illuminate how some human beings generate powerful, HIV-blocking antibodies. The results offer important insight into a potential AIDS vaccine design.

READ MORE

Blockchain & AI for Biomedical Applications

News

Biogerontology Research Foundation Chief Science Officer (CSO) co-authored the landmark paper in the journal Oncotarget on the convergence of blockchain and AI to decentralize and galvanize healthcare and biomedical research.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE